Am J Public Health 95:1889–1893PubMedCrossRef Beauchamp T, Childress J (2001) Principles of biomedical ethics, 5th edn. Oxford University Press, Oxford Benson JM, Therrell BL Jr (2010) History and current status of newborn screening for hemoglobinopathies. Semin Perinatol 34(2):134–144PubMedCrossRef Bernheim R, Nieburg P, Bonnie R (2007) Ethics and the practice of public health. In: Goodman R et al. (eds) Legal basis for public health practice, selleck inhibitor 2nd ed. Oxford University
Press, Oxford, pp 110–135 Botkin J, Clayton E, Fost N, Burke W, Murray T, Baily M, Wilfond B, Berg A, Ross L (2006) Newborn screening technology: proceed with caution. Pediatrics 117:1793–1799PubMedCrossRef Burchbinder M, Timmermans S (2011) Newborn screening and maternal diagnosis: rethinking family benefit. Soc Sci Med 73:1014–1018CrossRef Bush A, Gotz M (2006) Chapter 15: cystic fibrosis. In: Frey U, Gerritsen J (eds) Respiratory diseases in infants and children. European Respiratory Society Monograph, vol. 37. European Respiratory Society, Lausanne, pp 234–290 Cassol S, Butcher A, Kinard S, Spadoro J, Sy T, Lapointe N, Read S, Gomez P, Fauvel M, Major C (1994) Rapid screening for Rabusertib clinical trial early detection of mother-to-child
transmission of human immunodeficiency virus type 1. J Clin Microbiol 32:2641–2645PubMed Clague A, Thomas A (2002) Neonatal biochemical Orotidine 5′-phosphate decarboxylase screening for disease. Clin Chim Acta 315(1–2):99–110PubMedCrossRef Cochrane AL, Holland WW (1971) Validation of screening
procedures. Br Med Bull 27:35–38 Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, Warren ST (2009) Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 85:503–504PubMedCrossRef Crossley JR, Elliott RB, Smith PA (1979) Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 3:472–474CrossRef Ehrlich RM, McKendry JBJ (1973) Screening for congenital hypothyroidism in the newborn. Lancet 301:1121CrossRef European Commission Position Statement on Rare Diseases and Orphan Drugs (2010) EC regulation on orphan medicinal products. Downloaded December 2010 from: http://ec.europa.eu/health/rare_diseases/policy/index_en.htm Fisher DA (1991) Screening for congenital hypothyroidism. Trends Endocrinol Metab 2:129–133CrossRef Frank F, Fitzgerald R, Legge M (2007) Phenylketonuria—the lived experience. N Z Med J 120: http://www.nzma.org.nz/journal/120-1262/2728/. Accessed 17 Apr 2012 Garg U, Dasouki M (2006) Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects. Clin Biochem 39:315–332PubMedCrossRef Green NS, Dolan SM, Murray TH (2006) Human genes and human rights: newborn screening: complexities in universal genetic testing.